Creative Capital Management Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$506K Buy
4,003
+87
+2% +$11.5K 0.12% 45
2026
Q1
$546K Hold
3,916
0.16% 29
2025
Q4
$481K Buy
3,916
+12
+0.3% +$1.46K 0.15% 29
2025
Q3
$433K Hold
3,904
0.14% 30
2025
Q2
$433K Sell
3,904
-54
-1% -$5.75K 0.15% 29
2025
Q1
$443K Hold
3,958
0.17% 30
2024
Q4
$366K Buy
3,958
+393
+11% +$35.4K 0.15% 34
2024
Q3
$299K Buy
+3,565
New +$272K 0.12% 36

Other funds holding GILD

Creative Capital Management Investments's GILD Position: Q2 2026 in Review

Creative Capital Management Investments increased its Gilead Sciences (GILD) stake by 2.2% in Q2 2026, buying an estimated $11.5K and bringing the position to 4,003 shares worth $506K. The position accounts for 0.12% of the portfolio, ranked #45.

Creative Capital Management Investments first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $546K in Q1 2026. 758 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Creative Capital Management Investments held 4,003 shares of Gilead Sciences worth $506K as of Q2 2026.
  • Creative Capital Management Investments bought 87 Gilead Sciences shares in Q2 2026, an estimated $11.5K.
  • Gilead Sciences made up 0.12% of Creative Capital Management Investments's portfolio in Q2 2026, its #45 holding.
  • Creative Capital Management Investments first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • Creative Capital Management Investments's Gilead Sciences position peaked at $546K in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.